Akitakata, Japan

Daichi Kazamori

This inventor holds 1 USPTO granted patent. Top assignee: Wakunaga Pharmaceutical Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daichi Kazamori. Retrieved from https://idiyas.com/inventor/daichi-kazamori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daichi Kazamori: Innovator in Pyridonecarboxylic Acid Derivatives

Introduction: Daichi Kazamori, based in Akitakata, Japan, is a notable inventor recognized for his contributions to the field of chemistry. With a focus on pyridonecarboxylic acid derivatives, he holds a patent that showcases his innovative approach to molecular structure.

Latest Patents: Kazamori's patent involves a pyridonecarboxylic acid derivative or a salt thereof, represented by a complex formula. This includes various substituents such as hydrogen, halogen atoms, lower alkyl groups, and amino groups. The intricacies of his patent demonstrate a deep understanding of chemical structures, positioning him as a valuable contributor to pharmaceutical advancements.

Career Highlights: Working with Wakunaga Pharmaceutical Co., Ltd., Daichi Kazamori has made significant strides in the pharmaceutical industry. His research and innovation have the potential to lead to new therapeutic options, evidenced by his patented work on pyridonecarboxylic acid derivatives.

Collaborations: Throughout his career, Kazamori has collaborated with colleagues like Tomohiko Kinoshita and Yasuhiro Kuramoto. These partnerships within Wakunaga Pharmaceutical have likely fostered an environment of shared knowledge and creativity, aiding in the development of innovative solutions in their field.

Conclusion: Daichi Kazamori is an inventor whose work on pyridonecarboxylic acid derivatives is shaping the future of pharmaceutical research. His unique contributions and collaborations reflect his commitment to advancing scientific knowledge and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…